Neuland Laboratories Limited (BOM:524558)
India · Delayed Price · Currency is INR 23,536
-268 (-1.12%)
At close: Sep 11, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 301.97 billion as of September 11, 2026. Its market cap has increased by 59.19% in one year.
Market Cap
301.97B
Enterprise Value
304.21B
Revenue
23.72B
Ranking
n/a
PE Ratio
60.66
Stock Price
23,536.20
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 301.97B, an increase of 90,001.82%. That is a compound annual growth rate of 30.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 301.97B | 54.94% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 188.04B |
| Suven Life Sciences | 97.73B |
| Symbiotec Pharmalab | 70.30B |
| IOL Chemicals and Pharmaceuticals | 61.57B |
| Gujarat Themis Biosyn | 58.97B |
| NGL Fine-Chem | 17.32B |
| Bajaj HealthCare | 11.35B |
| Shree Ganesh Remedies | 8.55B |